A heterodimeric radioligand labeled with gallium-68 targeting fibroblast activation protein
Abstract Background Fibroblast activation protein (FAP) targeting radiotracers have emerged as promising agents for cancer imaging and therapy. Recent advancements have focused on optimizing these agents for better tumor targeting and enhanced theranostic efficacy. In this study, we introduced a nov...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-05-01
|
| Series: | EJNMMI Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13550-025-01230-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850284591846260736 |
|---|---|
| author | Chengde Xie Lei Peng Hui Nie Tianhong Yang Renbo Wu Dake Zhang Fuhua Wen Junyu Chen Lingyu Xue Xiangsong Zhang Zhihao Zha Jianjun Wang |
| author_facet | Chengde Xie Lei Peng Hui Nie Tianhong Yang Renbo Wu Dake Zhang Fuhua Wen Junyu Chen Lingyu Xue Xiangsong Zhang Zhihao Zha Jianjun Wang |
| author_sort | Chengde Xie |
| collection | DOAJ |
| description | Abstract Background Fibroblast activation protein (FAP) targeting radiotracers have emerged as promising agents for cancer imaging and therapy. Recent advancements have focused on optimizing these agents for better tumor targeting and enhanced theranostic efficacy. In this study, we introduced a novel heterodimeric radioligand labeled with gallium-68, which targets FAP. We aimed to evaluate its in vitro and in vivo performance, comparing its efficacy with monomeric FAPI derivatives. Results The heterodimeric ligand BiFAPI was synthesized by conjugating a cyclic peptide with a quinoline-based motif via a DOTA chelator. [68 Ga]Ga-BiFAPI demonstrated high radiochemical purity (> 95%) and exceptional stability in physiological conditions, as well as in both PBS and serum. In vitro studies revealed that the binding affinity of BiFAPI was comparable to that of FAP2286 and FAPI-04. Notably, [68 Ga]Ga-BiFAPI exhibited superior cellular uptake, with rapid internalization and slower efflux rates. Micro-PET/CT imaging in tumor-bearing mice demonstrated significantly higher tumor uptake than [68 Ga]Ga-FAP2286 and [68 Ga]Ga-FAPI-04. Co-injection with a FAP inhibitor reduced tumor uptake, confirming the tracer’s FAP specificity. In vitro autoradiography, immunohistochemistry, and Western blotting confirmed the correlation between radioactive tracer accumulation and FAP-positive regions. Biodistribution studies revealed high tumor-to-blood ratios and rapid clearance from non-target tissues, further supporting the tracer’s favorable pharmacokinetics. Conclusion [68 Ga]Ga-BiFAPI demonstrated superior tumor-targeting properties, higher tumor uptake, and favorable pharmacokinetics compared to [68 Ga]Ga-FAP2286 and [68 Ga]Ga-FAPI-04. Its promising performance in preclinical models positioned it as a potentially valuable agent for FAP-targeted PET imaging and cancer theranostics. |
| format | Article |
| id | doaj-art-d95d8b5c69234ca481b8559ee229c29f |
| institution | OA Journals |
| issn | 2191-219X |
| language | English |
| publishDate | 2025-05-01 |
| publisher | SpringerOpen |
| record_format | Article |
| series | EJNMMI Research |
| spelling | doaj-art-d95d8b5c69234ca481b8559ee229c29f2025-08-20T01:47:32ZengSpringerOpenEJNMMI Research2191-219X2025-05-0115111010.1186/s13550-025-01230-wA heterodimeric radioligand labeled with gallium-68 targeting fibroblast activation proteinChengde Xie0Lei Peng1Hui Nie2Tianhong Yang3Renbo Wu4Dake Zhang5Fuhua Wen6Junyu Chen7Lingyu Xue8Xiangsong Zhang9Zhihao Zha10Jianjun Wang11MOE Key Laboratory of Resources and EnvironmentalSystems Optimization, College of Environmental Scienceand Engineering, North China Electric Power UniversityDepartment of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen UniversityDepartment of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen UniversityDepartment of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen UniversityDepartment of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen UniversityDepartment of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen UniversityDepartment of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen UniversityMOE Key Laboratory of Resources and EnvironmentalSystems Optimization, College of Environmental Scienceand Engineering, North China Electric Power UniversityDepartment of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen UniversityDepartment of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen UniversityDepartment of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen UniversityMOE Key Laboratory of Resources and EnvironmentalSystems Optimization, College of Environmental Scienceand Engineering, North China Electric Power UniversityAbstract Background Fibroblast activation protein (FAP) targeting radiotracers have emerged as promising agents for cancer imaging and therapy. Recent advancements have focused on optimizing these agents for better tumor targeting and enhanced theranostic efficacy. In this study, we introduced a novel heterodimeric radioligand labeled with gallium-68, which targets FAP. We aimed to evaluate its in vitro and in vivo performance, comparing its efficacy with monomeric FAPI derivatives. Results The heterodimeric ligand BiFAPI was synthesized by conjugating a cyclic peptide with a quinoline-based motif via a DOTA chelator. [68 Ga]Ga-BiFAPI demonstrated high radiochemical purity (> 95%) and exceptional stability in physiological conditions, as well as in both PBS and serum. In vitro studies revealed that the binding affinity of BiFAPI was comparable to that of FAP2286 and FAPI-04. Notably, [68 Ga]Ga-BiFAPI exhibited superior cellular uptake, with rapid internalization and slower efflux rates. Micro-PET/CT imaging in tumor-bearing mice demonstrated significantly higher tumor uptake than [68 Ga]Ga-FAP2286 and [68 Ga]Ga-FAPI-04. Co-injection with a FAP inhibitor reduced tumor uptake, confirming the tracer’s FAP specificity. In vitro autoradiography, immunohistochemistry, and Western blotting confirmed the correlation between radioactive tracer accumulation and FAP-positive regions. Biodistribution studies revealed high tumor-to-blood ratios and rapid clearance from non-target tissues, further supporting the tracer’s favorable pharmacokinetics. Conclusion [68 Ga]Ga-BiFAPI demonstrated superior tumor-targeting properties, higher tumor uptake, and favorable pharmacokinetics compared to [68 Ga]Ga-FAP2286 and [68 Ga]Ga-FAPI-04. Its promising performance in preclinical models positioned it as a potentially valuable agent for FAP-targeted PET imaging and cancer theranostics.https://doi.org/10.1186/s13550-025-01230-wFAPPET imagingHeterodimericTheranostics |
| spellingShingle | Chengde Xie Lei Peng Hui Nie Tianhong Yang Renbo Wu Dake Zhang Fuhua Wen Junyu Chen Lingyu Xue Xiangsong Zhang Zhihao Zha Jianjun Wang A heterodimeric radioligand labeled with gallium-68 targeting fibroblast activation protein EJNMMI Research FAP PET imaging Heterodimeric Theranostics |
| title | A heterodimeric radioligand labeled with gallium-68 targeting fibroblast activation protein |
| title_full | A heterodimeric radioligand labeled with gallium-68 targeting fibroblast activation protein |
| title_fullStr | A heterodimeric radioligand labeled with gallium-68 targeting fibroblast activation protein |
| title_full_unstemmed | A heterodimeric radioligand labeled with gallium-68 targeting fibroblast activation protein |
| title_short | A heterodimeric radioligand labeled with gallium-68 targeting fibroblast activation protein |
| title_sort | heterodimeric radioligand labeled with gallium 68 targeting fibroblast activation protein |
| topic | FAP PET imaging Heterodimeric Theranostics |
| url | https://doi.org/10.1186/s13550-025-01230-w |
| work_keys_str_mv | AT chengdexie aheterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT leipeng aheterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT huinie aheterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT tianhongyang aheterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT renbowu aheterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT dakezhang aheterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT fuhuawen aheterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT junyuchen aheterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT lingyuxue aheterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT xiangsongzhang aheterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT zhihaozha aheterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT jianjunwang aheterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT chengdexie heterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT leipeng heterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT huinie heterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT tianhongyang heterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT renbowu heterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT dakezhang heterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT fuhuawen heterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT junyuchen heterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT lingyuxue heterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT xiangsongzhang heterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT zhihaozha heterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein AT jianjunwang heterodimericradioligandlabeledwithgallium68targetingfibroblastactivationprotein |